Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Evans' Syndrome in Adults: An Observational Multicentre Study

Bruno Fattizzo, MD, Marc Michel, Juri Alessandro Giannotta, MD, Dennis Lund Hansen, Montserrat Lopez Rubio, PhD, Emanuele Sutto, MD, Nicola Bianchetti, MD, Andrea Patriarca, MD, Silvia Cantoni, Maria Eva Mingot-Castellano, PhD MD, Vickie McDonald, MD, Marco Capecchi, MD, Josephine M.I Vos, Paola Bianchi, BSc, PhD, Nicola Vianelli, MD, Frederick Chen, MD, Henrik Frederiksen, MD PhD Prof, Tomas Jose Gonzalez-Lopez, Wilma Barcellini

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-136900

Published: 2020

Journal Articles

Prognostic Factors for Developing Thrombosis in Polycytemia Vera: A Retrospective Analysis of 331 Patients with Long-Term Follow-up Highlights the Importance of White Blood Cells Levels

Samantha Ferrari, MD, Chiara Pagani, MD, Mariella D'Adda, MD, Nicola Bianchetti, MD, Annamaria Pelizzari, MD, Doriana Gramegna, MD, Chiara Bottelli, MD, Luisa Lorenzi, MD, Gabriella Vona, Alessandra Tucci, MD, Giuseppe Rossi, MD

Blood (2020) 136 (Supplement 1): 48–49.

https://doi.org/10.1182/blood-2020-139431

Published: 2020

Journal Articles

Rituximab with Dose-Adjusted EPOCH (R-DA-EPOCH) As First-Line Treatment in Patients with Double-Hit Lymphoma: Preliminary Results in 35 Consecutive Patients from Two Institutions

Alessandra Tucci, MD, Anna Guidetti, MD, Anna Dodero, MD, Francesca Schieppati, MD, Alessandro Re, MD, Nicola Bianchetti, MD, Chiara Bottelli, MD, Angela Passi, MD, Maria Miscio, Simona Fisogni, MD, Piera Balzarini, Fabio Facchetti, MD, Paolo Corradini, MD, Giuseppe Rossi, MD

Blood (2017) 130 (Supplement 1): 4154.

https://doi.org/10.1182/blood.V130.Suppl_1.4154.4154

Published: 2017

Journal Articles

Aids Related Primary Central Nervous System Lymphoma Is Still a Challenge in the Cart Era: A Single Centre Experience

Alessandro Re, MD, Chiara Cattaneo, MD, Salvatore Casari, MD, Annalisa Peli, MD, Nicola Bianchetti, MD, Angela Passi, MD, Emanuele Focà, MD, Maria Miscio, Francesco Castelli, MD, Giuseppe Rossi, MD

Blood (2017) 130 (Supplement 1): 5223.

https://doi.org/10.1182/blood.V130.Suppl_1.5223.5223

Published: 2017

Journal Articles

Bortezomib-Based Induction Regimen Followed By Autologous Stem Cell Transplantation (ASCT) after Conditioning with MEL200 Is Highly Effective and Well Tolerated in Elderly Multiple Myeloma (MM) Patients up to the Age of 75 Years

Angelo Belotti, MD, Rossella Ribolla, MD, Claudia Crippa, MD, Chiara Cattaneo, MD, Enrico Morello, MD, Vincenza Orlando, PharmD, Nicola Bianchetti, MD, Samantha Ferrari, MD, Chiara Bottelli, MD, Francesca Schieppati, MD, Aldo M. Roccaro, Marco Chiarini, Mario Morone, MD, Giuseppe Rossi, MD

Blood (2017) 130 (Supplement 1): 3161.

https://doi.org/10.1182/blood.V130.Suppl_1.3161.3161

Published: 2017

NARROW

Evans' Syndrome in Adults: An Observational Multicentre Study

Prognostic Factors for Developing Thrombosis in Polycytemia Vera: A Retrospective Analysis of 331 Patients with Long-Term Follow-up Highlights the Importance of White Blood Cells Levels

Rituximab with Dose-Adjusted EPOCH (R-DA-EPOCH) As First-Line Treatment in Patients with Double-Hit Lymphoma: Preliminary Results in 35 Consecutive Patients from Two Institutions

Aids Related Primary Central Nervous System Lymphoma Is Still a Challenge in the Cart Era: A Single Centre Experience

Bortezomib-Based Induction Regimen Followed By Autologous Stem Cell Transplantation (ASCT) after Conditioning with MEL200 Is Highly Effective and Well Tolerated in Elderly Multiple Myeloma (MM) Patients up to the Age of 75 Years

Email alerts

ASH Publications

American Society of Hematology

Evans' Syndrome in Adults: An Observational Multicentre Study

Prognostic Factors for Developing Thrombosis in Polycytemia Vera: A Retrospective Analysis of 331 Patients with Long-Term Follow-up Highlights the Importance of White Blood Cells Levels

Rituximab with Dose-Adjusted EPOCH (R-DA-EPOCH) As First-Line Treatment in Patients with Double-Hit Lymphoma: Preliminary Results in 35 Consecutive Patients from Two Institutions

Aids Related Primary Central Nervous System Lymphoma Is Still a Challenge in the Cart Era: A Single Centre Experience

Bortezomib-Based Induction Regimen Followed By Autologous Stem Cell Transplantation (ASCT) after Conditioning with MEL200 Is Highly Effective and Well Tolerated in Elderly Multiple Myeloma (MM) Patients up to the Age of 75 Years

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only